Opaleye Management Inc. Quant / Systematic

Location: Boston, MA

CIK: 0001595855 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value: $116M (100.0% shares, 0.0% debt)

Holdings (27)

CHIMERIX INC 14.9%
Value $17.33M Shares 790,000 Est. Cost $22.55 Unrealized
RETROPHIN INC 12.3%
Value $14.28M Shares 1,216,400 Est. Cost $20.71 Unrealized
ARIAD PHARMACEUTICALS INC 9.1%
Value $10.57M Shares 1,660,000 Est. Cost $7100.00 Unrealized
PHARMACYCLICS INC 7.7%
Value $8.971M Shares 100,000 Est. Cost $108000.00 Unrealized
GENMARK DIAGNOSTICS INC 5.8%
Value $6.765M Shares 500,000 Est. Cost $10.41 Unrealized
BIND THERAPEUTICS INC 5.6%
Value $6.485M Shares 492,000 Est. Cost $4324.41 Unrealized
INSPIREMD INC 5.5%
Value $6.431M Shares 2,180,000 Est. Cost $1354.42 Unrealized
CEMPRA INC 4.7%
Value $5.417M Shares 504,800 Est. Cost $9402.92 Unrealized
CLOVIS ONCOLOGY INC 4.6%
Value $5.369M Shares 130,000 Est. Cost $41.30 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 4.5%
Value $5.269M Shares 115,000 Est. Cost $40.76 Unrealized 0.0%
CARDIOVASCULAR SYS INC DEL 3.6%
Value $4.207M Shares 135,000 Est. Cost $33000.00 Unrealized
CPRX CATALYST PHARM PARTNERS INC 3.0%
Value $3.488M Shares 1,378,584 Est. Cost $2.02 Unrealized +5.6%
INSYS THERAPEUTICS INC NEW 2.3%
Value $2.68M Shares 85,800 Est. Cost $31.24 Unrealized
TETRAPHASE PHARMACEUTICALS I 2.0%
Value $2.289M Shares 169,700 Est. Cost $11760.18 Unrealized
MAZOR ROBOTICS LTD 1.8%
Value $2.108M Shares 120,000 Est. Cost $17.57 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL IN 1.7%
Value $2.02M Shares 45,000 Est. Cost $41.17 Unrealized 0.0%
EVOKE PHARMA INC 1.7%
Value $1.962M Shares 242,500 Est. Cost $8.37 Unrealized
RECRO PHARMA INC 1.5%
Value $1.762M Shares 220,000 Est. Cost $8.01 Unrealized
CELGENE CORP 1.5%
Value $1.716M Shares 660,000 Est. Cost $2800.00 Unrealized
KARYOPHARM THERAPEUTICS INC 1.2%
Value $1.397M Shares 30,000 Est. Cost $46.57 Unrealized
BIOLINERX LTD 1.2%
Value $1.352M Shares 650,000 Est. Cost $1426.15 Unrealized
CDXS CODEXIS INC 1.0%
Value $1.197M Shares 820,000 Est. Cost $1.79 Unrealized -11.4%
CELATOR PHARMACEUTICALS INC 0.9%
Value $1.073M Shares 338,402 Est. Cost $2840.08 Unrealized
KALOBIOS PHARMACEUTICALS INC 0.6%
Value $730K Shares 320,000 Est. Cost $2145.33 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 0.4%
Value $455K Shares 7,200 Est. Cost $59.44 Unrealized 0.0%
KIPS BAY MED INC 0.3%
Value $355K Shares 772,031 Est. Cost $0.69 Unrealized
PRTA PROTHENA CORP PLC 0.3%
Value $295K Shares 13,104 Est. Cost $25.01 Unrealized 0.0%